Report cover image

Synairgen Plc - Strategic SWOT Analysis Review

Publisher GlobalData
Published Dec 29, 2025
Length 37 Pages
SKU # GBDT20700111

Description

Synairgen Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Synairgen Plc (Synairgen) is a biotechnology company. It is developing innovative therapies for respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) and viral infections like COVID-19. The company's main activity involves the research and development of inhaled interferon beta (IFN-ß) as a potential broad-spectrum antiviral treatment. It’s major product is SNG001, an inhaled formulation of IFN-ß designed to target the lungs directly aimed at treating severe viral lung infections by enhancing the body’s antiviral defense. Synairgen’s technological base includes a Biobank with clinical samples from asthma and COPD volunteers, which supports the creation of advanced human disease models and tissue engineering platforms. These models aid in discovering drug targets and supporting clinical trials. Synairgen is headquartered in Southampton, England, the UK.

Synairgen Plc Key Recent Developments

Jan 16,2025: Synairgen plc Martin Murphy appointed as Non-Executive Director
Jan 16,2025: Synairgen Appoints Martin Murphy as Non-Executive Director
Oct 10,2024: Synairgen Announces Results of Voting at Annual General Meeting
Sep 26,2024: Synairgen Releases Interim Results for Six Months Ended June 30, 2024

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

37 Pages
Section 1 - About the Company
Synairgen Plc - Key Facts
Synairgen Plc - Key Employees
Synairgen Plc - Key Employee Biographies
Synairgen Plc - Major Products and Services
Synairgen Plc - History
Synairgen Plc - Company Statement
Synairgen Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Synairgen Plc - Business Description
R&D Overview
Synairgen Plc - Corporate Strategy
Synairgen Plc - SWOT Analysis
SWOT Analysis - Overview
Synairgen Plc - Strengths
Synairgen Plc - Weaknesses
Synairgen Plc - Opportunities
Synairgen Plc - Threats
Synairgen Plc - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Synairgen Plc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Synairgen Plc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Synairgen Plc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jan 16, 2025: Synairgen Appoints Martin Murphy as Non-Executive Director
Jan 16, 2025: Synairgen plc Martin Murphy appointed as Non-Executive Director
Oct 10, 2024: Synairgen Announces Results of Voting at Annual General Meeting
Sep 26, 2024: Synairgen Releases Interim Results for Six Months Ended June 30, 2024
Sep 18, 2024: Synairgen : Appointment of New Chairman and Notice of AGM
Sep 18, 2024: Synairgen Announces Appointment of New Chairman and Notice of AGM
Sep 05, 2024: Synairgen Announces Board Change
Jun 27, 2024: Synairgen : Results for the year ended 31 December 2023
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Synairgen Plc, Key Facts
Synairgen Plc, Key Employees
Synairgen Plc, Key Employee Biographies
Synairgen Plc, Major Products and Services
Synairgen Plc, History
Synairgen Plc, Subsidiaries
Synairgen Plc, Key Competitors
Synairgen Plc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Synairgen Plc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Synairgen Plc, Recent Deals Summary
List of Figures
Synairgen Plc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Synairgen Plc, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us